Biotest AG
XBER:BIO
Biotest AG
XBER:BIO
Price:
42.6
EUR
Market Cap:
€1.7B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
B
|
Biotest AG
XBER:BIO
|
DE |
|
D
|
DR Horton Inc
SWB:HO2
|
US |
|
P
|
PTC Inc
XMUN:PMTA
|
US |
|
Bank of Nova Scotia
TSX:BNS
|
CA |
|
Ocugen Inc
NASDAQ:OCGN
|
US |
|
Resverlogix Corp
TSX:RVX
|
CA |
|
M
|
Medipal Holdings Corp
OTC:MAHLY
|
JP |
|
H
|
Hugo Boss AG
XHAM:BOSS
|
DE |
|
Catapult Group International Ltd
ASX:CAT
|
AU |
|
Cannagrow Holdings Inc
OTC:XONI
|
US |
|
B
|
Becton Dickinson and Co
SWB:BOX
|
US |
|
H
|
Hamborner REIT AG
XMUN:HABA
|
DE |
|
R
|
ReTo Eco-Solutions Inc
NASDAQ:RETO
|
CN |
|
Capitol Health Ltd
ASX:CAJ
|
AU |
|
Societe de Services de Participations, de Direction et d'Elaboration SA
XBRU:SPA
|
BE |
|
Aqua Metals Inc
NASDAQ:AQMS
|
US |
|
S
|
Summit Securities Ltd
NSE:SUMMITSEC
|
IN |
|
D
|
Discovery Ltd
JSE:DSY
|
ZA |
|
Gr Sarantis SA
OTC:SRTSF
|
GR |
|
West Fraser Timber Co Ltd
TSX:WFG
|
CA |
|
S
|
Skyverse Technology Co Ltd
SSE:688361
|
CN |
|
A
|
American Green Group Inc
OTC:AMNE
|
US |
|
Veidekke ASA
F:VK4
|
NO |
|
Dios Fastigheter AB
STO:DIOS
|
SE |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BIO's stock price target?
Not Available
BIO does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Biotest AG?
Projected CAGR
-1%
-1%
Over the last 8 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 1 year is -1%.
What is the Operating Income forecast for Biotest AG?
Projected CAGR
25%
25%
Over the last 8 years, the compound annual growth rate for Operating Income has been 12%. The projected CAGR for the next 1 year is 25%.
What is the Net Income forecast for Biotest AG?
Projected CAGR
121%
121%
The compound annual growth rate for Net Income over the next 1 year is 121%.
